A Phase 1, Open-label Study to Evaluate the Safety and Tolerability of MEDI0680 (AMP-514) in Combination with MEDI4736 in Subjects with Advanced Malignancies

Type of Cancer
Unknown

Sponsor
Medimmune

Protocol Number
D6020C00001

To Learn More Call
201-510-0910